# Faeth Therapeutics, Inc.: Form 8-K, filed Apr 16, 2026

- Company: [Faeth Therapeutics, Inc.](/companies/fth.md) (CIK 1829802)
- Form: 8-K
- Filed: 2026-04-16
- Accepted by EDGAR: Apr 16, 2026, 16:02 ET
- Period: 2026-04-10
- Accession: 0001193125-26-158951
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829802/000119312526158951/d85136d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829802/000119312526158951/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829802/000119312526158951/d85136d8k.htm

Filed Apr 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-158951. Last ingested by Listed: Nov 14, 2026, 19:01 ET. No prices; not investment advice.
